Protocol for study M20-339 Parkinson's disease (H-51814)
Description
Content
A comparative study of Levodopa and Carbidopa bioavailability following Foslevodopa/Foscarbidopa infusion at different subcutaneous sites in Parkinson's Disease patients
This is a comparative study of Levodopa and Carbidopa bioavailability following foslevodopa/foscarbidopa infusion at different subcutaneous sites in Parkinson's disease patients.
Contact
Phone 1: 713–798–5989
IRB: H-51814
Status:
Active
Created:
